Literature DB >> 30851545

Lin28 promotes dental pulp cell proliferation via upregulation of cyclin-dependent proteins and interaction with let-7a/IGF2BP2 pathways.

Yan Liu1, Ning Dong2, Jiyu Miao3, Chenxing Li4, Xiaofei Wang3, Jianping Ruan5.   

Abstract

Caries, pulpitis, and trauma are the main causes of dental pulp damage. The regeneration capacity of dental pulp declines with age. Lin28 is a conserved RNA-binding protein in higher eukaryotes that regulates several important cellular functions associated with development, glucose metabolism, differentiation, and pluripotency. Conditional reactivation of Lin28 gene in adult mice markedly accelerates the wound-healing process in injured digits. However, little is known about its functions and molecular mechanism in human dental pulp. The aim of this study was to investigate the effects and mechanism of overexpression of Lin28 gene on the proliferation of human dental pulp cells (HDPCs). For this purpose, a number of molecular and biochemical analytical techniques, including the ethynyl-2'-deoxyuridine (EdU) incorporation assay, RNA-protein immunoprecipitation (RIP) analysis, and luciferase assays, were used for detailed characterization. In addition, factors regulating HDPCs activation were explored through gain-of-function and loss-of-function analyses. The results demonstrate that Lin28 promotes cell proliferation and the S-G2/M transition of HDPCs and directly binds to a group of cell cycle regulatory mRNAs in HDPCs. Through bioinformatics analysis and luciferase assays, we confirmed that let-7a targets IGF2BP2. Silencing of IGF2BP2 showed similar cellular and molecular effects as let-7a. Similarly, restoration of IGF2BP2 counteracted the effects of let-7a expression. In conclusion, Lin28 promotes cell proliferation by regulation of both mRNA translation (let-7-independent) and miRNA biogenesis (let-7-dependent). Lin28 can promote the expression of pro-proliferative genes by directly enhancing their translation to maintain a tight control over HDPC proliferation.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Human dental pulp cells; Lin28; Proliferation; RNA-protein immunoprecipitation; let-7a/IGF2BP2

Mesh:

Substances:

Year:  2019        PMID: 30851545     DOI: 10.1016/j.biopha.2019.108742

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  The role of insulin-like growth factor 2 mRNA binding proteins in female reproductive pathophysiology.

Authors:  Xiao Xu; Hao-Ran Shen; Jia-Rong Zhang; Xue-Lian Li
Journal:  Reprod Biol Endocrinol       Date:  2022-06-15       Impact factor: 4.982

Review 2.  Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer.

Authors:  Evgeny Chirshev; Kerby C Oberg; Yevgeniya J Ioffe; Juli J Unternaehrer
Journal:  Clin Transl Med       Date:  2019-08-28

3.  Insulin-like growth factor 2 mRNA binding protein 2 regulates proliferation, migration, and angiogenesis of keratinocytes by modulating heparanase stability.

Authors:  Shaomin Zhi; Jun Li; Xiao Kong; Xuemei Xie; Qiangli Zhang; Guoxiang Fang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Lin28a induces SOX9 and chondrocyte reprogramming via HMGA2 and blunts cartilage loss in mice.

Authors:  Yohan Jouan; Zohra Bouchemla; Benoit Bardèche-Trystram; Joanna Sana; Caroline Andrique; Hang-Korng Ea; Pascal Richette; Augustin Latourte; Martine Cohen-Solal; Eric Hay
Journal:  Sci Adv       Date:  2022-08-26       Impact factor: 14.957

5.  3' UTR-truncated HMGA2 overexpression induces non-malignant in vivo expansion of hematopoietic stem cells in non-human primates.

Authors:  Melissa A Bonner; Antonio Morales-Hernández; Sheng Zhou; Zhijun Ma; Jose Condori; Yong-Dong Wang; Soghra Fatima; Lance E Palmer; Laura J Janke; Stephanie Fowler; Brian P Sorrentino; Shannon McKinney-Freeman
Journal:  Mol Ther Methods Clin Dev       Date:  2021-05-01       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.